Linde Moved Its U.S. Homecare Unit Into 'Other' The Quarter It Took $183 Million In Non-Cash Charges
The segment recast lifted Americas margins to 35.1% while profit in Other fell 32% to $42 million.
Linde, the industrial gases maker, moved its U.S. homecare business out of the Americas segment and into "Other" in the same quarter it booked $183 million of non-cash charges tied mainly to that business, according to its third-quarter 10-Q filed Thursday.
A $425 million charge, and where it landed
The cost-reduction program charge totaled $425 million for the quarter. It comprises $200 million of severance, $42 million of other cost-reduction costs and the $183 million of non-cash charges, which the company ties primarily to U.S. homecare.
Reported operating profit fell 9% to $2,150 million, and the filing says the charge drove the decline. Reported EPS dropped 11% to $3.66, while adjusted EPS, which strips out the charge and merger purchase accounting, rose 9% to $4.59.
In the prior quarter's 10-Q, the company reported no such charges for the quarter.
Americas looks better, Other looks worse
Under the revised structure, Americas posted sales of $3,601 million and operating profit of $1,263 million, a 35.1% margin. The second-quarter filing, with homecare still inside Americas, showed a 31.2% margin. Prior periods have been recast, the company said.
Other, which also holds corporate costs, Linde Advanced Material Technologies and global helium wholesale, reported sales of $944 million. Its operating profit fell 32% to $42 million from $62 million, which the filing attributes primarily to declines in U.S. homecare, partly offset by growth in LAMT.
Segment results exclude the cost-reduction charge, so the $183 million does not sit in either segment's operating profit.
Russia exposure and the stock
Linde makes oxygen, nitrogen, hydrogen and other gases, delivered by pipeline, truck and cylinder, and builds gas plants through its Engineering arm. Sales for 2025 were $33,986 million.
The filing says a Stockholm arbitration tribunal ruled on October 15 that Gazprom's Amur project claims must go to arbitration and barred Gazprom from enforcing the related Russian judgment. Gazprom may challenge the award, and Linde carries a $0.7 billion contingent liability for Amur matters, plus a $1.1 billion one tied to terminated RusChemAlliance projects.
Linde shares traded at $501.70 in Thursday trading, as of 11:06 a.m. ET, down about 1%. Employees ended September at 64,512, down 977 from a year earlier, which the filing attributes to cost-reduction programs partly offset by acquisitions.
For the fourth quarter, Linde guides to adjusted EPS of $4.40 to $4.50, and for the full year $17.82 to $17.92, the company said.
Sources
- 10-Q Filing — Linde (LIN) — SEC EDGAR
- 10-Q Filing — Linde (LIN), Q2 FY2026 filed 2026-07-31 (comparison basis) — SEC EDGAR
- Earnings release (8-K Item 2.02, lin_ex991.htm) — Linde, filed 2026-10-29 — SEC EDGAR
- EQS-News: Linde Reports Third-Quarter 2026 Results (Earnings Release Tables Attached) – Company Announcement - FT.com — Financial Times
- Linde Reports Third-Quarter 2026 Results – Company Announcement - FT.com — Financial Times
- Linde lifts FY earnings outlook as Q3 beats street views (LIN:NASDAQ) | Seeking Alpha — seekingalpha.com
- Linde (LIN) Surpasses Q3 Earnings and Revenue Estimates — Yahoo Finance
- Linde Gears Up to Report Q3 Earnings: What's in Store for the Stock? — Yahoo Finance